Early Video-assisted Thoracoscopic Surgery versus Tube Thoracostomy in Stage II (Fibrinopurulent) Pediatric Empyema: A Randomized Controlled Trial
Journal of Indian Association of Pediatric Surgeons · 2026-11 · 31 (6) · 917-922
DOI: 10.4103/jiaps.jiaps_210_26 ↗Abstract
A BSTRACT Background: Empyema thoracis remains a significant complication of pediatric pneumonia, associated with substantial morbidity. While tube thoracostomy is widely used as first-line treatment, early video-assisted thoracoscopic surgery (VATS) has emerged as a minimally invasive alternative with promising outcomes. Objective: The objective of the study was to compare clinico-radiological outcomes of early VATS versus tube thoracostomy in children with empyema and assess long-term pulmonary recovery. Materials and Methods: A randomized controlled trial was conducted over 18 months, including 44 children (≤12 years) with empyema thoracis. Patients were randomized into early VATS ( n = 22) and tube thoracostomy ( n = 22) groups. Outcomes included symptom resolution, duration of intercostal drainage, antibiotic therapy, hospital stay, radiological resolution, and pulmonary function. Results: Baseline characteristics were comparable. Early VATS resulted in significantly faster fever resolution (1.73 vs. 10.27 days, P < 0.001), shorter chest drain duration (5.10 vs. 22.36 days, P < 0.001), reduced antibiotic requirement, and shorter hospital stay (19.41 vs. 25.41 days, P < 0.01). Radiological and functional outcomes at 6 months were similar in both groups. Conclusion: Early VATS provides superior short-term outcomes without compromising long-term recovery and should be considered the preferred treatment modality to reduce acute morbidity, drainage duration, antibiotic exposure, and hospital stay in Stage II (fibrinopurulent) pediatric empyema. This short-term advantage is clinically significant in its own right, translating into reduced morbidity for children and lower burden on the healthcare system.
EUVIMED